Brief: ESSA Pharma Reports Financial Results For Fiscal Second Quarter Ended March 31, 2025
08/05/2025 12:25
May 8 (Reuters) - ESSA Pharma Inc EPIX.O: ESSA PHARMA REPORTS FINANCIAL RESULTS FOR FISCAL SECOND QUARTER ENDED MARCH 31, 2025 ESSA PHARMA INC - CONTINUES TO EVALUATE STRATEGIC OPTIONS ESSA PHARMA INC - REPORTS $6.4 MILLION NET LOSS FOR Q2 2025 Source text: ID:nPn1K3r1a Further company coverage: EPIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ESSA Pharma
See all newsBrief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: ESSA Pharma Provides Update On Its Application To The Supreme Court Of British Columbia For Amended Interim Order
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics